Global Cardiopulmonary Assisted Membrane Oxygenator Market Growth 2025-2031--LP INFORMATION, INC.

Global Cardiopulmonary Assisted Membrane Oxygenator Market Growth 2025-2031

Product Code: 1539179

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 91

Delivery Time: 2-3 business days

Global Cardiopulmonary Assisted Membrane Oxygenator Market Growth 2025-2031

Product Code: 1539179

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 91

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Cardiopulmonary Assisted Membrane Oxygenator market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Extracorporeal   Membrane Oxygenation (ECMO) is an extracorporeal life support device used to   support and replace patients with severe heart or lung failure. ECMO helps   maintain normal oxygen levels and carbon dioxide removal in the body by   draining the patient's blood from the body to a device outside the body where   gas exchange (oxygenation and carbon dioxide removal) occurs and then   returning the blood to the body.

United States market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cardiopulmonary Assisted Membrane Oxygenator is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cardiopulmonary Assisted Membrane Oxygenator players cover GETINGE, PROCIRCA, Perfusion Solution, Vivacity Perfusion, SpecialtyCare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Cardiopulmonary Assisted Membrane Oxygenator Industry Forecast” looks at past sales and reviews total world Cardiopulmonary Assisted Membrane Oxygenator sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Assisted Membrane Oxygenator sales for 2025 through 2031. With Cardiopulmonary Assisted Membrane Oxygenator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Assisted Membrane Oxygenator industry.

This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Assisted Membrane Oxygenator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Assisted Membrane Oxygenator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiopulmonary Assisted Membrane Oxygenator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Assisted Membrane Oxygenator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Assisted Membrane Oxygenator.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Assisted Membrane Oxygenator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    VA (veno-arterial) ECMO

    VV (veno-venous) ECMO

Segmentation by Application:

    Hospital

    Clinic

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    GETINGE

    PROCIRCA

    Perfusion Solution

    Vivacity Perfusion

    SpecialtyCare

    Keystone Perfusion Services

    Comprehensive Care Services

    Memorial

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiopulmonary Assisted Membrane Oxygenator market?

What factors are driving Cardiopulmonary Assisted Membrane Oxygenator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiopulmonary Assisted Membrane Oxygenator market opportunities vary by end market size?

How does Cardiopulmonary Assisted Membrane Oxygenator break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Cardiopulmonary Assisted Membrane Oxygenator by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Cardiopulmonary Assisted Membrane Oxygenator by Country/Region, 2020, 2024 & 2031
    2.2 Cardiopulmonary Assisted Membrane Oxygenator Segment by Type
        2.2.1 VA (veno-arterial) ECMO
        2.2.2 VV (veno-venous) ECMO
    2.3 Cardiopulmonary Assisted Membrane Oxygenator Sales by Type
        2.3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
        2.3.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Type (2020-2025)
    2.4 Cardiopulmonary Assisted Membrane Oxygenator Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Others
    2.5 Cardiopulmonary Assisted Membrane Oxygenator Sales by Application
        2.5.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2020-2025)
        2.5.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Breakdown Data by Company
        3.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Company (2020-2025)
        3.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company (2020-2025)
    3.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Company (2020-2025)
        3.2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company (2020-2025)
        3.2.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company (2020-2025)
    3.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Company
    3.4 Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Product Location Distribution
        3.4.2 Players Cardiopulmonary Assisted Membrane Oxygenator Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Cardiopulmonary Assisted Membrane Oxygenator by Geographic Region
    4.1 World Historic Cardiopulmonary Assisted Membrane Oxygenator Market Size by Geographic Region (2020-2025)
        4.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country/Region (2020-2025)
        4.2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
    4.4 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
    4.5 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Growth
    4.6 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Growth

5 Americas
    5.1 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country
        5.1.1 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025)
        5.1.2 Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2020-2025)
    5.2 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025)
    5.3 Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region
        6.1.1 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2020-2025)
        6.1.2 APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2020-2025)
    6.2 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025)
    6.3 APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Cardiopulmonary Assisted Membrane Oxygenator by Country
        7.1.1 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025)
        7.1.2 Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2020-2025)
    7.2 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025)
    7.3 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator by Country
        8.1.1 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2020-2025)
    8.2 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025)
    8.3 Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Cardiopulmonary Assisted Membrane Oxygenator
    10.3 Manufacturing Process Analysis of Cardiopulmonary Assisted Membrane Oxygenator
    10.4 Industry Chain Structure of Cardiopulmonary Assisted Membrane Oxygenator

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Cardiopulmonary Assisted Membrane Oxygenator Distributors
    11.3 Cardiopulmonary Assisted Membrane Oxygenator Customer

12 World Forecast Review for Cardiopulmonary Assisted Membrane Oxygenator by Geographic Region
    12.1 Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Forecast by Region
        12.1.1 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Region (2026-2031)
        12.1.2 Global Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Type (2026-2031)
    12.7 Global Cardiopulmonary Assisted Membrane Oxygenator Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 GETINGE
        13.1.1 GETINGE Company Information
        13.1.2 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.1.3 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 GETINGE Main Business Overview
        13.1.5 GETINGE Latest Developments
    13.2 PROCIRCA
        13.2.1 PROCIRCA Company Information
        13.2.2 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.2.3 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 PROCIRCA Main Business Overview
        13.2.5 PROCIRCA Latest Developments
    13.3 Perfusion Solution
        13.3.1 Perfusion Solution Company Information
        13.3.2 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.3.3 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Perfusion Solution Main Business Overview
        13.3.5 Perfusion Solution Latest Developments
    13.4 Vivacity Perfusion
        13.4.1 Vivacity Perfusion Company Information
        13.4.2 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.4.3 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Vivacity Perfusion Main Business Overview
        13.4.5 Vivacity Perfusion Latest Developments
    13.5 SpecialtyCare
        13.5.1 SpecialtyCare Company Information
        13.5.2 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.5.3 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 SpecialtyCare Main Business Overview
        13.5.5 SpecialtyCare Latest Developments
    13.6 Keystone Perfusion Services
        13.6.1 Keystone Perfusion Services Company Information
        13.6.2 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.6.3 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Keystone Perfusion Services Main Business Overview
        13.6.5 Keystone Perfusion Services Latest Developments
    13.7 Comprehensive Care Services
        13.7.1 Comprehensive Care Services Company Information
        13.7.2 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.7.3 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Comprehensive Care Services Main Business Overview
        13.7.5 Comprehensive Care Services Latest Developments
    13.8 Memorial
        13.8.1 Memorial Company Information
        13.8.2 Memorial Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
        13.8.3 Memorial Cardiopulmonary Assisted Membrane Oxygenator Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Memorial Main Business Overview
        13.8.5 Memorial Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Cardiopulmonary Assisted Membrane Oxygenator Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Cardiopulmonary Assisted Membrane Oxygenator Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of VA (veno-arterial) ECMO
 Table 4. Major Players of VV (veno-venous) ECMO
 Table 5. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
 Table 6. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
 Table 7. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Type (2020-2025)
 Table 9. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Type (2020-2025) & (US$/Unit)
 Table 10. Global Cardiopulmonary Assisted Membrane Oxygenator Sale by Application (2020-2025) & (Units)
 Table 11. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2020-2025)
 Table 12. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Application (2020-2025)
 Table 14. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Application (2020-2025) & (US$/Unit)
 Table 15. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Company (2020-2025) & (Units)
 Table 16. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company (2020-2025)
 Table 17. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company (2020-2025)
 Table 19. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Price by Company (2020-2025) & (US$/Unit)
 Table 20. Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Producing Area Distribution and Sales Area
 Table 21. Players Cardiopulmonary Assisted Membrane Oxygenator Products Offered
 Table 22. Cardiopulmonary Assisted Membrane Oxygenator Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Region (2020-2025) & (Units)
 Table 26. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Country/Region (2020-2025) & (Units)
 Table 30. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025) & (Units)
 Table 34. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country (2020-2025)
 Table 35. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
 Table 37. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025) & (Units)
 Table 38. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2020-2025) & (Units)
 Table 39. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Region (2020-2025)
 Table 40. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
 Table 42. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025) & (Units)
 Table 43. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025) & (Units)
 Table 44. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
 Table 46. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025) & (Units)
 Table 47. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Country (2020-2025) & (Units)
 Table 48. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
 Table 50. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025) & (Units)
 Table 51. Key Market Drivers & Growth Opportunities of Cardiopulmonary Assisted Membrane Oxygenator
 Table 52. Key Market Challenges & Risks of Cardiopulmonary Assisted Membrane Oxygenator
 Table 53. Key Industry Trends of Cardiopulmonary Assisted Membrane Oxygenator
 Table 54. Cardiopulmonary Assisted Membrane Oxygenator Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Cardiopulmonary Assisted Membrane Oxygenator Distributors List
 Table 57. Cardiopulmonary Assisted Membrane Oxygenator Customer List
 Table 58. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Region (2026-2031) & (Units)
 Table 59. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2026-2031) & (Units)
 Table 61. Americas Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Region (2026-2031) & (Units)
 Table 63. APAC Cardiopulmonary Assisted Membrane Oxygenator Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2026-2031) & (Units)
 Table 65. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Country (2026-2031) & (Units)
 Table 67. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Type (2026-2031) & (Units)
 Table 69. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Forecast by Application (2026-2031) & (Units)
 Table 71. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. GETINGE Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 73. GETINGE Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 74. GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. GETINGE Main Business
 Table 76. GETINGE Latest Developments
 Table 77. PROCIRCA Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 78. PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 79. PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. PROCIRCA Main Business
 Table 81. PROCIRCA Latest Developments
 Table 82. Perfusion Solution Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 83. Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 84. Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Perfusion Solution Main Business
 Table 86. Perfusion Solution Latest Developments
 Table 87. Vivacity Perfusion Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 88. Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 89. Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Vivacity Perfusion Main Business
 Table 91. Vivacity Perfusion Latest Developments
 Table 92. SpecialtyCare Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 93. SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 94. SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. SpecialtyCare Main Business
 Table 96. SpecialtyCare Latest Developments
 Table 97. Keystone Perfusion Services Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 98. Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 99. Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Keystone Perfusion Services Main Business
 Table 101. Keystone Perfusion Services Latest Developments
 Table 102. Comprehensive Care Services Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 103. Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 104. Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Comprehensive Care Services Main Business
 Table 106. Comprehensive Care Services Latest Developments
 Table 107. Memorial Basic Information, Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base, Sales Area and Its Competitors
 Table 108. Memorial Cardiopulmonary Assisted Membrane Oxygenator Product Portfolios and Specifications
 Table 109. Memorial Cardiopulmonary Assisted Membrane Oxygenator Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Memorial Main Business
 Table 111. Memorial Latest Developments


List of Figures
 Figure 1. Picture of Cardiopulmonary Assisted Membrane Oxygenator
 Figure 2. Cardiopulmonary Assisted Membrane Oxygenator Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Growth Rate 2020-2031 (Units)
 Figure 7. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2024)
 Figure 10. Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of VA (veno-arterial) ECMO
 Figure 12. Product Picture of VV (veno-venous) ECMO
 Figure 13. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type in 2025
 Figure 14. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Type (2020-2025)
 Figure 15. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Hospital
 Figure 16. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Hospital (2020-2025) & (Units)
 Figure 17. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Clinic
 Figure 18. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Clinic (2020-2025) & (Units)
 Figure 19. Cardiopulmonary Assisted Membrane Oxygenator Consumed in Others
 Figure 20. Global Cardiopulmonary Assisted Membrane Oxygenator Market: Others (2020-2025) & (Units)
 Figure 21. Global Cardiopulmonary Assisted Membrane Oxygenator Sale Market Share by Application (2024)
 Figure 22. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Application in 2025
 Figure 23. Cardiopulmonary Assisted Membrane Oxygenator Sales by Company in 2025 (Units)
 Figure 24. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Company in 2025
 Figure 25. Cardiopulmonary Assisted Membrane Oxygenator Revenue by Company in 2025 ($ millions)
 Figure 26. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Company in 2025
 Figure 27. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales 2020-2025 (Units)
 Figure 30. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue 2020-2025 ($ millions)
 Figure 31. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales 2020-2025 (Units)
 Figure 32. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue 2020-2025 ($ millions)
 Figure 33. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales 2020-2025 (Units)
 Figure 34. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales 2020-2025 (Units)
 Figure 36. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue 2020-2025 ($ millions)
 Figure 37. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country in 2025
 Figure 38. Americas Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
 Figure 40. Americas Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2020-2025)
 Figure 41. United States Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Region in 2025
 Figure 46. APAC Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
 Figure 48. APAC Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2020-2025)
 Figure 49. China Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country in 2025
 Figure 57. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
 Figure 59. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2020-2025)
 Figure 60. Germany Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Cardiopulmonary Assisted Membrane Oxygenator Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Cardiopulmonary Assisted Membrane Oxygenator in 2025
 Figure 74. Manufacturing Process Analysis of Cardiopulmonary Assisted Membrane Oxygenator
 Figure 75. Industry Chain Structure of Cardiopulmonary Assisted Membrane Oxygenator
 Figure 76. Channels of Distribution
 Figure 77. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

GETINGE

PROCIRCA

Perfusion Solution

Vivacity Perfusion

SpecialtyCare

Keystone Perfusion Services

Comprehensive Care Services

Memorial

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff